Irritable Bowel Syndrome News

SAN DIEGO — Crohn’s disease patients who reported using nonsteroidal anti-inflammatory drugs more than once per week demonstrated a significantly higher risk for active disease compared with those who used them less often, a speaker said here.

Platelet-depleted plasma concentrations of serotonin were linked to symptom severity and rectal insensitivity in patients with functional constipation and IBS with constipation in a recent study.

Patients with acute diverticulitis were more likely to develop irritable bowel syndrome, according to a recent retrospective study.

Patients with IBS and visceral hypersensitivity are more likely to experience lactose intolerance symptoms, particularly bloating, according to recent results.

Patients with nonceliac gluten sensitivity and IBS benefited from diets low in fermentable, poorly absorbed, short-chain carbohydrates but did not experience symptom changes after gluten introduction in a recent study.

Patients with irritable bowel syndrome with diarrhea treated with eluxadoline had better rates of clinical response and indicated more symptom improvement than placebo recipients in a recent study.

Patients with IBS-related constipation experienced significantly better outcomes than placebo recipients after treatment with polyethylene glycol 3350 with electrolytes in a recent study.

ORLANDO, Fla. — Patients with irritable bowel syndrome who experienced abdominal bloating had significantly different intestinal microbiota composition than those without bloating, according to data presented at Digestive Disease Week.

ORLANDO, Fla. — Patients with irritable bowel syndrome or ulcerative colitis had similarly increased prevalence of depression and/or anxiety compared with controls in a study presented at Digestive Disease Week.

Patients with irritable bowel syndrome had similarly elevated scores on the Crohn’s disease activity index as patients with Crohn’s disease in a recent study.